Latigo Biotherapeutics News and Activities

Acquisition, funding and merger involving Latigo Biotherapeutics.

• Latigo Biotherapeutics has just announced a $150 Million fundraising (posted on March 24 2025).
• Latigo Biotherapeutics has just announced a $150 Million fundraising (posted on February 25 2025).

View the org chart displaying its 23 main executives

Most searched biographies at Latigo Biotherapeutics

• Nima Farzan, Chief Executive Officer
• Deborah Palestran, Director
• Kevin Raidy, Director

Popular executive movements at Latigo Biotherapeutics

• Sara Bonstein has joined the company as Director  (posted on April 13 2026).
• Timothy Lugo, Chief Financial Officer, has left the company  (posted on March 4 2026).

Create your alert
to follow the executive moves at Latigo Biotherapeutics.

Latigo Biotherapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Latigo Biotherapeutics

Social media about Latigo Biotherapeutics

• Latigo Biotherapeutics on Wikipedia, Google News & Yahoo Finance
• Latigo Biotherapeutics on LinkedIn, X (Twitter) & YouTube